212 related articles for article (PubMed ID: 27918947)
1. The effect of blood staining on cervicovaginal quantitative fetal fibronectin concentration and prediction of spontaneous preterm birth.
Hezelgrave NL; Kuhrt K; Cottam K; Seed PT; Tribe RM; Shennan AH
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():103-108. PubMed ID: 27918947
[TBL] [Abstract][Full Text] [Related]
2. Quantitative fetal fibronectin predicts preterm birth in women with bulging fetal membranes.
Fiorini F; Isted A; Hezelgrave NL; Shennan AH
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():127-31. PubMed ID: 27280542
[TBL] [Abstract][Full Text] [Related]
3. Quantitative fetal fibronectin and cervical length to predict preterm birth in asymptomatic women with previous cervical surgery.
Vandermolen BI; Hezelgrave NL; Smout EM; Abbott DS; Seed PT; Shennan AH
Am J Obstet Gynecol; 2016 Oct; 215(4):480.e1-480.e10. PubMed ID: 27267388
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of additive effect of quantitative fetal fibronectin to cervical length for prediction of spontaneous preterm birth among asymptomatic high-risk women.
Tran TL; Jwala S; Terenna C; McGregor A; Das A; Baxter JK; Berghella V
J Matern Fetal Neonatal Med; 2020 Aug; 33(15):2628-2634. PubMed ID: 30612481
[No Abstract] [Full Text] [Related]
5. The use of quantitative fetal fibronectin for the prediction of preterm birth in women with exposed fetal membranes undergoing emergency cervical cerclage.
Suff N; Hall M; Shennan A; Chandiramani M
Eur J Obstet Gynecol Reprod Biol; 2020 Mar; 246():19-22. PubMed ID: 31923878
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of additive effect of quantitative fetal fibronectin to cervical length for prediction of spontaneous preterm birth among asymptomatic low-risk women.
Jwala S; Tran TL; Terenna C; McGregor A; Andrel J; Leiby BE; Baxter JK; Berghella V
Acta Obstet Gynecol Scand; 2016 Aug; 95(8):948-55. PubMed ID: 27100022
[TBL] [Abstract][Full Text] [Related]
7. Mid-gestational changes in cervicovaginal fluid cytokine levels in asymptomatic pregnant women are predictive markers of inflammation-associated spontaneous preterm birth.
Amabebe E; Chapman DR; Stern VL; Stafford G; Anumba DOC
J Reprod Immunol; 2018 Apr; 126():1-10. PubMed ID: 29367099
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a tool incorporating cervical length and quantitative fetal fibronectin to predict spontaneous preterm birth in asymptomatic high-risk women.
Kuhrt K; Smout E; Hezelgrave N; Seed PT; Carter J; Shennan AH
Ultrasound Obstet Gynecol; 2016 Jan; 47(1):104-9. PubMed ID: 25846437
[TBL] [Abstract][Full Text] [Related]
9. Blind vaginal fetal fibronectin swab for prediction of preterm birth.
Farag AH; Mohammed MM; Ellaithy MI; Salama HA
J Obstet Gynaecol Res; 2015 Jul; 41(7):1009-17. PubMed ID: 25771777
[TBL] [Abstract][Full Text] [Related]
10. Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study
Levine LD; Downes KL; Romero JA; Pappas H; Elovitz MA
J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3792-3800. PubMed ID: 29727248
[No Abstract] [Full Text] [Related]
11. Predictive Accuracy of Serial Transvaginal Cervical Lengths and Quantitative Vaginal Fetal Fibronectin Levels for Spontaneous Preterm Birth Among Nulliparous Women.
Esplin MS; Elovitz MA; Iams JD; Parker CB; Wapner RJ; Grobman WA; Simhan HN; Wing DA; Haas DM; Silver RM; Hoffman MK; Peaceman AM; Caritis SN; Parry S; Wadhwa P; Foroud T; Mercer BM; Hunter SM; Saade GR; Reddy UM;
JAMA; 2017 Mar; 317(10):1047-1056. PubMed ID: 28291893
[TBL] [Abstract][Full Text] [Related]
12. The use of fetal fibronectin and cervical length measurements in the prediction of spontaneous preterm birth in women with an Arabin pessary in situ.
Martin A; Suff N; Seed PT; David AL; Girling J; Shennan A
Eur J Obstet Gynecol Reprod Biol; 2022 Sep; 276():113-117. PubMed ID: 35853271
[TBL] [Abstract][Full Text] [Related]
13. Prediction of spontaneous preterm birth using quantitative fetal fibronectin after recent sexual intercourse.
McLaren JS; Hezelgrave NL; Ayubi H; Seed PT; Shennan AH
Am J Obstet Gynecol; 2015 Jan; 212(1):89.e1-5. PubMed ID: 24992691
[TBL] [Abstract][Full Text] [Related]
14. Cervical length and quantitative fetal fibronectin in the prediction of spontaneous preterm birth in asymptomatic women with congenital uterine anomaly.
Ridout AE; Ibeto LA; Ross GN; Cook JR; Sykes L; David AL; Seed PT; Tribe RM; Bennett PR; Terzidou V; Shennan AH; Chandiramani M; ; Brown RG; Chatfield S; Sadeh D
Am J Obstet Gynecol; 2019 Oct; 221(4):341.e1-341.e9. PubMed ID: 31132343
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor.
Ravi M; Beljorie M; El Masry K
J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3909-3914. PubMed ID: 29807458
[No Abstract] [Full Text] [Related]
16. A Combination of Cervicovaginal Fluid Glutamate, Acetate and D-Lactate Identified Asymptomatic Low-Risk Women Destined to Deliver Preterm: a Prospective Cohort Study.
Amabebe E; Anumba DOC
Reprod Sci; 2022 Mar; 29(3):915-922. PubMed ID: 34374963
[TBL] [Abstract][Full Text] [Related]
17. The Preterm Prediction Study: association between cervical interleukin 6 concentration and spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
Goepfert AR; Goldenberg RL; Andrews WW; Hauth JC; Mercer B; Iams J; Meis P; Moawad A; Thom E; VanDorsten JP; Caritis SN; Thurnau G; Miodovnik M; Dombrowski M; Roberts J; McNellis D;
Am J Obstet Gynecol; 2001 Feb; 184(3):483-8. PubMed ID: 11228507
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women.
Abbott DS; Radford SK; Seed PT; Tribe RM; Shennan AH
Am J Obstet Gynecol; 2013 Feb; 208(2):122.e1-6. PubMed ID: 23164760
[TBL] [Abstract][Full Text] [Related]
19. Quantitative fetal fibronectin to predict preterm birth in asymptomatic women at high risk.
Abbott DS; Hezelgrave NL; Seed PT; Norman JE; David AL; Bennett PR; Girling JC; Chandirimani M; Stock SJ; Carter J; Cate R; Kurtzman J; Tribe RM; Shennan AH
Obstet Gynecol; 2015 May; 125(5):1168-1176. PubMed ID: 25932845
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of predictive models for QUiPP App v.2: tool for predicting preterm birth in asymptomatic high-risk women.
Watson HA; Seed PT; Carter J; Hezelgrave NL; Kuhrt K; Tribe RM; Shennan AH
Ultrasound Obstet Gynecol; 2020 Mar; 55(3):348-356. PubMed ID: 31325332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
